Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis; Open-labelled, Single Center, Phase 1 Study

NCT04610359 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT04610359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04610359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis; Open-labelled, Single Center, Phase 1 Study
Lead sponsor
Asan Medical Center
Phase
Phase 1
Overall status
Unknown status
Start date
October 20, 2020
Completion date
December 31, 2022
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis, mesenchymal stem cell, stem cell transplant